ResearcherHouston MethodistActive in the last 2 years
Yeon‐Ju Lee
Matched on ORCID iD 0000-0003-4814-943X; OpenAlex author ID A5003528434. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 46
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 8
- Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarci… First author DOI 10.1038/s41418-024-01387-2↗
- Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41418-018-0207-3↗
- Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1200/po.19.00001↗
- Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therap… Co-author DOI 10.1002/cncr.31251↗
- A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. First author DOI 10.1158/1078-0432.ccr-17-3668↗
- Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2017.06.026↗
- Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Co-author DOI 10.1158/1078-0432.ccr-15-2780↗
- Human equilibrative nucleoside transporter-1 knockdown tunes cellular mechanics through epithelial-mesenchymal transition in pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0107973↗
Closest collaborators
The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eugene Jon Koay · 8 shared papers, 2014–2024 · strength 0.63
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Jason B. Fleming · 6 shared papers, 2016–2024 · strength 0.52
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Ya’an Kang · 5 shared papers, 2016–2024 · strength 0.46
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal ad… DOI 10.1016/j.canlet.2017.06.026↗
- Mayrim V. Rios Perez · 4 shared papers, 2016–2024 · strength 0.40
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Michael P. Kim · 3 shared papers, 2018–2024 · strength 0.35
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Xinqun Li · 3 shared papers, 2016–2024 · strength 0.35
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocar… DOI 10.1158/1078-0432.ccr-15-2780↗
- Rolf A. Brekken · 2 shared papers, 2019–2024 · strength 0.30
- Paper Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenv… DOI 10.1038/s41418-024-01387-2↗
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Mohamed Zaid · 4 shared papers, 2017–2019 · strength 0.24
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal ad… DOI 10.1016/j.canlet.2017.06.026↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Matthew H. G. Katz · 4 shared papers, 2016–2019 · strength 0.22
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Huamin Wang · 4 shared papers, 2016–2019 · strength 0.22
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Eric Peter Tamm · 3 shared papers, 2018–2019 · strength 0.18
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Robert A. Wolff · 3 shared papers, 2018–2019 · strength 0.18
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Priya Bhosale · 3 shared papers, 2018–2019 · strength 0.18
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Anirban Maitra · 3 shared papers, 2018–2019 · strength 0.18
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Gauri Rajani Varadhachary · 3 shared papers, 2018–2019 · strength 0.18
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Christopher H. Crane · 3 shared papers, 2018–2019 · strength 0.18
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Jeffrey E. Lee · 3 shared papers, 2018–2019 · strength 0.18
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Mauro Ferrari B · 3 shared papers, 2014–2018 · strength 0.16
- Paper Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal ad… DOI 10.1016/j.canlet.2017.06.026↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Human equilibrative nucleoside transporter-1 knockdown tunes cellular mechanics through epithelial-mesenchymal transiti… DOI 10.1371/journal.pone.0107973↗
- Bingbing Dai · 2 shared papers, 2016–2019 · strength 0.14
- Paper Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancr… DOI 10.1038/s41418-018-0207-3↗
- Paper Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocar… DOI 10.1158/1078-0432.ccr-15-2780↗
- Sunil Krishnan Krishnan · 2 shared papers, 2018–2019 · strength 0.13
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Rachna T. Shroff · 2 shared papers, 2018–2019 · strength 0.12
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Milind M. Javle · 2 shared papers, 2018–2019 · strength 0.12
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Ahmed M. Amer · 2 shared papers, 2018 · strength 0.11
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Cullen M. Taniguchi · 2 shared papers, 2018 · strength 0.11
- Paper Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography sca… DOI 10.1002/cncr.31251↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Deyali Chatterjee · 2 shared papers, 2016–2018 · strength 0.10
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocar… DOI 10.1158/1078-0432.ccr-15-2780↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.